Nvidia among investors in xAI’s $20 bln capital raise- Bloomberg
Director Moore Duncan sold 75,000 shares of ASP Isotopes Inc. (NASDAQ:ASPI) on August 29, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The shares were sold at a weighted average price of $9.2831, for a total value of $696,232. The stock, which has delivered a remarkable 275% return over the past year according to InvestingPro data, has recently experienced increased volatility.
The prices for the sales ranged from $8.95 to $10.20. This sale was to cover income tax liabilities from the vesting of a restricted stock award. Following the transaction, Moore Duncan directly owns 994,553 shares of ASP Isotopes Inc. With a market capitalization of $797 million and its next earnings report due September 3, 2025, investors can access comprehensive analysis and 13 additional key insights through InvestingPro’s detailed research report.
In other recent news, ASP Isotopes Inc. announced the pricing of a $60 million offering of common stock, with shares set at $8.00 each. This offering is expected to close soon, providing significant capital before expenses. Additionally, ASP Isotopes and Fermi America have signed a Memorandum of Understanding to develop a High Assay Low Enriched Uranium (HALEU) enrichment facility in Texas, using advanced laser-based technology. In a related move, ASP Isotopes and its subsidiary Quantum Leap Energy LLC have agreed to form a joint venture with Fermi America for nuclear fuel production. This collaboration aims to enhance the supply of HALEU for small modular reactors.
Furthermore, ASP Isotopes has invested $5 million in IsoBio, a radiotherapeutic development company, to aid in the creation of antibody-isotope conjugates targeting cancer cells. In leadership news, ASP Isotopes appointed Dr. Ryno Pretorius as CEO of its subsidiary, Quantum Leap Energy LLC. Dr. Pretorius brings extensive experience in nuclear fuel development and technology scale-up. These developments reflect ASP Isotopes’ strategic initiatives in nuclear fuel production and biotechnological advancement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.